The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LP-002438 from04/22/2014 issued to KRKA-RUS LLC, Russia):
Rixila® (trade name of the medicinal product)
Aliskiren (international non-proprietary or grouping or chemical name)
tablets, film-coated 50 mg, 300 mg (dosage form, dosage)
Limited Liability Company "KRKA-RUS" (OOO KRKA-RUS), Russia 143500, Moscow Region, Istra, ul. Moscow, 50 (name and address of the location of the manufacturer of the medicinal product)
on the basis of filing by an authorized legal entity OOO "KRKA-RUS" application of the drug.